
RIPK1-IN-4
CAS No. 1481641-08-0
RIPK1-IN-4( —— )
Catalog No. M33106 CAS No. 1481641-08-0
RIPK1-IN-4 is a potent and selective type II kinase receptor interacting protein 1 (RIP1) kinase inhibitor and binds to a DLG-out inactive form of RIP1 (IC50s of 16 nM and 10 nM for RIP1 and ADP-Glo kinase).
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 105 | Get Quote |
![]() ![]() |
5MG | 163 | Get Quote |
![]() ![]() |
10MG | 259 | Get Quote |
![]() ![]() |
25MG | 415 | Get Quote |
![]() ![]() |
50MG | 585 | Get Quote |
![]() ![]() |
100MG | 772 | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameRIPK1-IN-4
-
NoteResearch use only, not for human use.
-
Brief DescriptionRIPK1-IN-4 is a potent and selective type II kinase receptor interacting protein 1 (RIP1) kinase inhibitor and binds to a DLG-out inactive form of RIP1 (IC50s of 16 nM and 10 nM for RIP1 and ADP-Glo kinase).
-
DescriptionRIPK1-IN-4 (compound 8) is a potent and selective type II kinase inhibitor of receptor interacting protein 1 (RIP1) kinase and binds to a DLG-out inactive form of RIP1 with an IC50s of 16 nM and 10 nM for RIP1 and ADP-Glo kinase.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayApoptosis
-
TargetRIP kinase
-
RecptorRIP kinase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1481641-08-0
-
Formula Weight401.46
-
Molecular FormulaC23H23N5O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 250 mg/mL (622.73 mM; Ultrasonic )
-
SMILESCC(C)(C)c1cc(NC(=O)Nc2ccc(cc2)-c2cccc3c(N)nccc23)no1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Harris PA, et al. Discovery of Small Molecule RIP1 Kinase Inhibitors for the Treatment of Pathologies Associated with Necroptosis. ACS Med Chem Lett. 2013 Nov 4;4(12):1238-43.?
molnova catalog



related products
-
Necroptosis-IN-1
Necroptosis-IN-1 is a potent necroptosis inhibitor of RIPK1. It is an analog of Necrostatin-1.
-
Sibiriline
A specific competitive RIPK1 inhibitor with IC50 of 1.03 uM, 100-fold less potent for RIPK3.
-
GSK-872
GSK-872 (GSK 872) is a potent and selective RIPK3 (receptor-interacting protein kinase-3) inhibitor.